green
Positive treatment
Quoted verbatim 1×
5.7 score
“a law will not be interpreted in such a way as to make it meaningless”
Treatment trajectory · 1993 → 2026 · click a year to view as-of
1993
2009
2026
Top citers, strongest first. 19 distinct citers.
How cited ↗
discussed
Cited as authority (quoted)
Langham v. State
a law will not be interpreted in such a way as to make it meaningless
cited
Cited "see"
Duvall v. Bristol-Myers-Squibb Co.
See King v. Collagen Corp., 983 F.2d 1130, 1131 (1st Cir.) (Torraella, J.), cert. denied, 510 U.S. 824 , 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
cited
Cited "see"
Eugene Duvall Patricia Sue Duvall v. Bristol-Myers-Squibb Company, a Delaware Corporation Medical Engineering Corporation, A/K/A Surgitek/medical Engineering Corporation, and Food & Drug Administration, Amicus Curiae. Eugene Duvall Patricia Sue Duvall v. Bristol-Myers-Squibb Company, a Delaware Corporation Medical Engineering Corporation, A/K/A Surgitek/medical Engineering Corporation
See King v. Collagen Corp., 983 F.2d 1130, 1131 (1st Cir.) (Torruella, J.), cert. denied, 510 U.S. 824 , 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
discussed
Cited "see"
Wilson v. Bradlees
Mendes, 18 F.3d at 16 ; see Levesgue v. Miles, Inc., 816 F. Supp. 61, 64 (D.N.H. 1993) (when faced with express preemption, "the only remaining question is whether a particular state statute [or cause of 1The court's finding of express preemption forecloses inquiry into implied preemption "because the fact that Congress included it in the [statute] implies that matters beyond its reach are not preempted." Levesgue, 816 F. Supp. at 68 (quoting King v. Collagen Corp., 983 F.2d 1130, 1134 (1st Cir.), cert. dismissed, 114 S. Ct. 84 (1993)). 7 action] intrudes into the federal pale").
cited
Cited "see"
Duvall v. Bristol-Myers-Squibb
See King v. Collagen Corp., 983 F.2d 1130, 1131 (1st Cir.) (Torruella, J.), cert. denied, --- U.S. ----, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
cited
Cited "see"
Duvall v. Bristol-Myers-Squibb Co.
See King v. Collagen Corp., 983 F.2d 1130, 1131 (1st Cir.) (Torraella, J.), cert. denied, — U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
cited
Cited "see"
Estate of LeMay Ex Rel. LeMay v. Eli Lilly & Co.
See King v. Collagen Corp., 983 F.2d 1130, 1134 (1st Cir.), cert. denied — U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993); Stamps v. Collagen Corp., 984 F.2d at 1421-22 .
discussed
Cited "see"
Nina Michael v. Shiley, Inc. Hospital Products Group, Inc., (Formerly Howmedica, Inc.) Pfizer, Inc
(2×)
Accord King v. Collagen Corp., 983 F.2d 1130, 1135 (1st Cir.), cert. denied, — U.S.-, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
cited
Cited "see"
Michael v. Shiley, Inc.
Accord King v. Collagen Corp., 983 F.2d 1130, 1135 (1st Cir.), cert. denied, 114 S. Ct. 84 (1993).
cited
Cited "see"
prod.liab.rep. (Cch) P 14,061 National Bank of Commerce of El Dorado, as Administrator of the Estate of Margaret Armon Wilson, Deceased v. Kimberly-Clark Corporation
See King v. Collagen Corp., 983 F.2d 1130, 1135-36 (1st Cir.), cert. denied, --- U.S. ----, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993). 41 FDA has classified menstrual tampons as Class II medical devices.
cited
Cited "see"
National Bank of Commerce ex rel. Estate of Wilson v. Kimberly-Clark Corp.
See King v. Collagen Corp., 983 F.2d 1130, 1135-36 (1st Cir.), cert. denied, — U.S. —, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
discussed
Cited "see"
Bravman v. Baxter Healthcare Corp.
See King v. Collagen Corp., 983 F.2d 1130 (1st Cir.) (“King ”), cert. denied, — U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993); Stamps v. Collagen Corp., 984 F.2d 1416 (5th Cir.) {“Stamps”), cert. denied, 114 S.Ct. 86 (1993).
cited
Cited "see"
New Hampshire Motor Transport Ass'n v. Town of Plaistow
See King v. Collagen Corp., 983 F.2d 1130 (1st Cir.1993) (express preemption provisions foreclose inquiry into implied preemption), ce rt. denied — U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
discussed
Cited "see, e.g."
Mears v. Marshall
Bard, Inc., 865 F Supp 37, 45 (D Mass 1994), affd 63 F3d 25 (1st Cir 1995) (citing four federal circuit court cases and four federal district court cases so holding); see also King v. Collagen Corp., 983 F2d 1130, 1140 (1st Cir), cert den [510] US [824], 114 S Ct 84 , 126 L Ed 2d 52 (1993) (no implied right of action).
discussed
Cited "see, e.g."
Worthy v. Collagen Corp.
(2×)
See, e.g., King v. Collagen Corp., 983 F.2d 1130, 1139 (1st Cir.), cert. denied, ___ U.S. ___, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993) (when statute is clear, agency interpretation must give way); Talbott v. C.R.
discussed
Cited "see, e.g."
28 Ucc rep.serv.2d 531, prod.liab.rep. (Cch) P 14,411 Ada M. Martin Harold L. Martin v. Telectronics Pacing Systems, Inc.
Compare King v. Collagen Corp., 983 F.2d 1130, 1135 (1st Cir.) (holding express warranty claims preempted), ce rt. denied, — U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993) and Duvall, 65 F.3d at 400-01 (holding express warranty claims based on FDA-mandated labeling, packaging, or advertising preempted) with Michael v. Shiley, Inc., 46 F.3d 1316, 1327 (3rd Cir.) (holding express warranty claims not preempted), cert. denied, — U.S.-, 116 S.Ct. 67 , 133 L.Ed.2d 29 (1995) and Mitchell, 67 F.3d at 1284-85 (following Michael).
cited
Cited "see, e.g."
Mastrangelo v. Howmedica
See id. § 808.1(b); see also King v. Collagen Corp., 983 F.2d 1130, 1134 (1st Cir.), cert. denied, — U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
discussed
Cited "see, e.g."
Mears v. Marshall
Bard, Inc., 865 F Supp 37, 45 (D Mass 1994), aff’d 63 F3d 25 (1st Cir 1995) (citing four federal circuit court cases and four federal district court cases so holding); see also King v. Collagen Corp., 983 F2d 1130, 1140 (1st Cir), cert den_US_, 114 S Ct 84 , 126 L Ed 2d 52 (1993) (no implied right of action). *395 The FDA, upon recommendation of its Surgical and Rehabilitation Devices Panel, approved Collagen’s PMA application for Zyderm by letter on July 22, 1981, and by order published on September 18, 1991. 46 Fed Reg 46,394 (1981).
discussed
Cited "see, e.g."
Committee of Dental Amalgam Alloy Manufacturers v. Henry
See Stamps v. Collagen Corp., 984 F.2d 1416, 1421 (5th Cir.) (premarket approval procedure, applicable to all Class III devices, preempts state tort claims for defective design, inadequate warning and negligent failure to warn), cert. denied, - U.S. -, 114 S.Ct. 86 , 126 L.Ed.2d 54 (1993); see also King v. Collagen Corp., 983 F.2d 1130, 1134-35 (1st Cir.1993) (approval of device’s labelling and packaging during Class III premarket approval process preempts state tort claims), cert. denied, - U.S. -, 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993).
Retrieving the full opinion text from the archive…
NATIONAL UNION FIRE INSURANCE COMPANY OF PITTSBURGH, PENNSYLVANIA
v.
Leonard HELFAND, et ux.
v.
Leonard HELFAND, et ux.
No. 92-1974.
Supreme Court of the United States.
Oct 4, 1993.
114 S. Ct. 84
Cited by 1 opinion | Published
Citer courts: Court of Criminal Appeals of A… (1)
Petition for writ of certiorari to the Court of Appeal of California, First Appellate District, denied.